Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Byondis B.V.
Four new orphan medicines were among the products recommended for pan-EU marketing approval by the European Medicines Agency this week.
The European Medicines Agency is this week due to decide whether to recommend pan-EU marketing authorization for a number of new products.
Oncology's surprisingly low numbers this year are among the latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Upcoming user fees include 16 novel agents, featuring two RSV vaccines, two gene therapies, and three oncologics. The Pink Sheet’s US FDA Performance Tracker breaks down the big month to come.
- Drug Delivery
- Generic Drugs
- Specialty Pharmaceuticals
- Synthesis Technologies, Production Processes
- Other Names / Subsidiaries
- Synthon Biopharmaceuticals B.V.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.